Net sales for the American market increased by 2 percent during the second quarter while the Europe net sales decreased by 8 percent and the international sales increased by 12 percent. The company foresees an improving economy, favorable demographics and product innovation to lead to a successful future.
Knee sales increased by 2 percent worldwide, extremity sales by 21 percent and sports medicine sales by 16 percent worldwide. The sales of spine products experienced a 3 percent decrease during the second quarter.
Read the release on Biomet’s 2Q FY 2011 financial report.
Read other coverage on Biomet:
– Biomet Completes Enrollment for FDA Trial for PRP Device for Tennis Elbow Treatment
– Biomet Nederland, Small Bone Innovations Sign Distribution Agreement
– Biomet Acquires Massachusetts’ Cytosol Laboratories
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
